Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.903 SEK | -2.58% | -2.03% | -62.14% |
15/04 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
04/04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.14% | 27.25M | |
+8.96% | 105B | |
-1.43% | 104B | |
+5.59% | 22.94B | |
-12.15% | 22.34B | |
-5.80% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides : CFO to Leave